While supporting the role of ER-beta as a tumor suppressor via the inhibition of ER-alpha-induced cell proliferation [86], some researchers assume a contrary shift from ER-alpha to ER-beta signaling during the estrogen-dependent progression of endometriosis to EAOC [87,88]. Here, ESR2 is linked to neoplasm.